These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 344042)

  • 1. Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
    Jansen EN
    Eur Neurol; 1978; 17(2):92-9. PubMed ID: 344042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
    Gron U
    Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine in the treatment of advanced Parkinsonism.
    Kristensen O; Hansen E
    Acta Neurol Scand; 1977 Sep; 56(3):274-6. PubMed ID: 333856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
    Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive therapy with bromocriptine in Parkinson's disease.
    Temlett JA; Ming A; Saling M; Fritz VU; Blumenfeld A; Bilchik TR; Becker AL; Fourie PB; Reef HE
    S Afr Med J; 1990 Dec; 78(11):680-5. PubMed ID: 2251616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R; Shoulson I; Calne DB
    Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
    Delwaide PJ; Schoenen J
    Rev Med Liege; 1983 May; 38(9):362-6. PubMed ID: 6867529
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
    Laihinen A; Rinne UK; Suchy I
    Acta Neurol Scand; 1992 Dec; 86(6):593-5. PubMed ID: 1481646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of bromocriptine in the treatment of Parkinson's disease.
    Mackenzie RA; Lance JW
    Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB; Smith NJ
    J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine: low-dose therapy in Parkinson disease.
    Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
    Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of parkinsonism with bromocriptine.
    Calne DB; Plotkin C; Williams AC; Nutt JG; Neophytides A; Teychenne PF
    Lancet; 1978 Apr; 1(8067):735-8. PubMed ID: 76747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplification of the initiation of bromocriptine in elderly patients with advanced Parkinson's disease.
    MacMahon DG; Overstall PW; Marshall T
    Age Ageing; 1991 Mar; 20(2):146-51. PubMed ID: 2053506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects.
    Micieli G; Martignoni E; Cavallini A; Pacchetti C; Rossi F; Horowski R; Nappi G
    Funct Neurol; 1996; 11(6):317-25. PubMed ID: 9074912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Sydney multicentre study of Parkinson's disease. The first 18 months.
    Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
    Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
    Agid Y; Pollak P; Bonnet AM; Signoret JL; Lhermitte F
    Lancet; 1979 Mar; 1(8116):570-2. PubMed ID: 85162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
    Rinne UK
    Neurology; 1987 May; 37(5):826-8. PubMed ID: 3574685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN; Meerwaldt JD
    Adv Neurol; 1987; 45():539-42. PubMed ID: 3103396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL; Rascol O; Rascol A
    Rev Neurol (Paris); 1990; 146(2):144-7. PubMed ID: 2181588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.